Next »
Contraception
Volume 67, Issue 1
, Pages 1-8
, January 2003
Amenorrhea associated with contraception—an international study on acceptability
References
-
.
In: The control of fertility. New York and London: Academic Press; 1965;p. 219
- . The epidemiology of hysterectomy, findings in a large cohort study. Br J Obstet Gynaecol. 1992;99:402–407
-
.
Women’s attitudes to withdrawal bleeding and their knowledge and beliefs about the oral contraceptive pill.
Med J Australia. 1988;149:417–419
- . Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use. Contraception. 1999;59:357–362
-
.
Is menstruation obsolete?. New York: Oxford University Press; 1999;
- . Nuisance or natural and healthy (should monthly menstruation be optional for women?). Lancet. 2000;355:922–924
- . Menstruation (choosing whether… and when). Contraception. 2000;62:277–284
- . A cross-cultural study of menstruation (implications for contraceptive development and use). Stud Fam Plann. 1981;12:3–16
- . Do women want a once-a-month pill?. Hum Reprod. 1999;14:3018–3022
- . Is postpartum contraceptive advice given antenatally of value?. Contraception. 2002;65:237–243
-
.
The evolution of human reproduction.
In:
Short RV, Baird DT editor. Contraceptives of the future. London: The Royal Society; 1996;p. 3–21
-
In:
Berer M, Ravindran TKS, Cottingham J editor. Beyond acceptability (users perspectives on contraception). London: Reproductive Health Matters for WHO; 1997;
- . Acceptability of an oral contraceptive that reduces the frequency of menstruation (the tri-cycle pill regimen). Br Med J. 1977;2:487–490
-
.
A tri-monthly regimen for oral contraceptives.
Br J Fam Plann. 1994;19:274–275
- . Long-interval treatment regimen with a desogestrel-containing oral contraceptive. Contraception. 1987;48:205–216
- . Menstrual reduction with extended use of combined oral contraceptive pills (randomized controlled trial). Obstet Gynecol. 2001;98:771–778
- . Is norethisterone a lifestyle drug? Results of a database analysis. BMJ. 2000;320:291
- . Daily low dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: a double-blind randomised control trial of 2 and 5 mg per day for 120 days. J Clin Endocrinol Metab. 2002;87:63–70
PII: S0010-7824(02)00474-2
doi: 10.1016/S0010-7824(02)00474-2
© 2003 Elsevier Science Inc. All rights reserved.
Next »
Contraception
Volume 67, Issue 1
, Pages 1-8
, January 2003
